- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
7 Pearls from New Pediatric Obesity Guidelines
Evidence-based clinical practice guidelines address the assessment, treatment, and prevention of child and teen obesity.
Evidence-based clinical practice guidelines for the assessment, treatment, and prevention of pediatric obesity have been released by the Endocrine Society as an update of earlier guidelines.Pediatric obesity is a persistent serious international health concern affecting about 17% of United States children and adolescents. Elevated BMI among US youths aged 6 to 19 years is associated with $1.4 billion in additional health care costs for outpatient visits and other care vs youths of the same age with normal BMIs.The guidelines specify three cutpoints designating overweight and obesity for children and adolescents: ⺠Overweight: BMI between 85th and 95th percentile for age/gender ⺠Obese: BMI ⥠95th percentile for age/gender ⺠Extremely obese: BMI ⥠120% of 95th percentileAn Endocrine Society task force commissioned 2 systematic reviews and used evidence from other published systematic reviews and individual studies. Scroll through the slides above for their main conclusions. SourcePediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice GuidelineÂ
